To help clarify the mechanisms by which volatile anaesthetics act on neuronal Ca 2ϩ channel currents (I Ba ), the effects of isoflurane were studied on I Ba in rat dorsal root ganglion (DRG) cells. Voltage-dependent I Ba were pharmacologically subdivided into L-, N-and P/Q-types, and toxin-resistant I Ba . At clinically relevant concentrations, isoflurane inhibited the L-, N-and P/Q-types, but not toxin-resistant I Ba . The IC 50 values for the L-, N-and P/Q-types were 0.7%, 1.3% and 3.0%, respectively (concentrations equivalent to 0.35, 0.68 and 1.46 mmol litre -1 in the aqueous phase). Isoflurane also produced initial transient augmentation of the N-type I Ba . Isoflurane shifted the mid-point of the steady-state inactivation curve for the L-, N-and P/Qtype I Ba towards negative potentials, and prolonged the time constant of current reactivation. We conclude that isoflurane inhibited L-, N-and P/Q-type I Ba in rat DRG neurones by enhancing current inactivation and prolonging recovery time after inactivation. Transient augmentation of the N-type I Ba may also form part of the overall actions of isoflurane in DRG neurones.
Most anaesthetics inhibit excitatory and enhance inhibitory synaptic transmission in both the central and peripheral parts of the nervous system. The former action results from block of Ca 2ϩ influx in various types of cells via inhibition of voltage-dependent Ca 2ϩ channels in addition to inhibition of excitatory agonist receptors, such as nicotinic acetylcholine 1 and glutamate receptors, 2 whereas the latter results from augmentation of gamma-aminobutyric acid receptors. 3 To date, six types of Ca 2ϩ current have been classified pharmacologically and on molecular biological grounds: T-, L-, N-, P-, Q-and R-type Ca 2ϩ channels. 4 Although the precise physiological roles of these calcium currents in the nervous system have not yet been elucidated, the N-and P/Q-types have important roles in synaptic transmission at the neuromuscular junction, 5 and inhibition of these channels in the central nervous system may lead to effects such as loss of consciousness, loss of sensation, and circulatory and respiratory depression.
Volatile anaesthetics have been reported to reduce the voltage-dependent Ca 2ϩ current (I Ba ) via actions on L-or T-type I Ba , or both, in dog myocytes, 6 in coronary artery smooth muscle cells 7 and in a thyroid c-cell line. 8 With © British Journal of Anaesthesia regard to the actions of isoflurane on the other high-voltage activated I Ba (L-, N-, P-, Q-and R-types) this volatile anaesthetic has been reported to inhibit the N-type and another type of I Ba , probably the P-type, in addition to the L-type (all to much the same extent) in rat hippocampal pyramidal neurones. 9 In contrast, relatively minor inhibition of the P-type I Ba was produced by isoflurane in rat cerebellar Purkinje neurones. 10 However, these reports were based on results obtained using a single concentration of isoflurane, and no precise conclusion on the mechanism underlying the inhibitory actions of this agent could be reached. For a full understanding of the actions of isoflurane on synaptic transmission, it is important to know if isoflurane acts on specific calcium channels at clinically relevant concentrations. To investigate this, we used rat dorsal root ganglion (DRG) cells, as these neurones have multiple calcium channels, including the L-, N-, P/Q-types and toxin-resistant I Ba , which were pharmacologically isolated using a combination of two toxins, such as calsiceptine (L-type blocker), ω-conotoxin GVIA (N-type blocker) and ω-agatoxin IVA (P/Q-type blocker), respectively. [11] [12] [13] 
Materials and methods

Cell preparation
DRG cells were obtained from 1-10-day-old Wistar rats. DRG were dissected out and incubated at 37°C for 30 min in physiological salt solution (PSS) (mmol litre -1 : NaCl 125, KCl 5, CaCl 2 1.8, MgCl 2 1, HEPES 5, glucose 20) containing collagenase 1 mg ml -1 (Wako Pure Chemicals, Osaka, Japan) and trypsin 0.5 mg ml -1 (Sigma Chem., St Louis, MO, USA), and then triturated gently by 5~10 passages using a fire-polished Pasteur pipette. The dispersed cells were re-suspended in fresh PSS and stored in an icebox. Cells were then seeded onto glass cover slips (13 mm in diameter) coated with poly-L-lysine (Sigma Chem.) and transferred to a chamber mounted on the stage of an inverted microscope (Diaphoto 300; Nikon, Tokyo, Japan). Electrical recordings were made at room temperature (25-28°C), 12 h or less after isolation. Small neurones (diameter Ͻ30 µm, membrane capacitance 20-50 pF) were selected for I Ba recording. 11 13 
Solutions and drugs
An internal pipette solution with the following ionic composition was used (mmol litre -1 : Cs aspartate 135, MgCl 2 5, glucose 12, BAPTA (Dojin, Kumamoto, Japan) 5, HEPES 10, Na 2 ATP (Sigma Chem.) 5), and pH was adjusted to 7.0 using CsOH. The following external solution was superfused in the bath (mmol litre -1 : Tris-Cl 100, CsCl 5, BaCl 2 5, MgCl 2 1, TEA-Cl 25, HEPES 5, glucose 20), and pH was adjusted to 7.4 using HCl.
Using an agent-specific anaesthetic vaporizer, isoflurane was vaporized in 100% oxygen (1 ml min -1 ). The external solution was bubbled with the appropriate concentration of isoflurane in a reservoir for at least 15 min before application to cells. Control solutions were bubbled with 100% oxygen gas. The concentration of isoflurane in the gas phase was verified using an anaesthetic gas analyser (Type 303; ATOM, Tokyo, Japan). Although the concentration of isoflurane in the aqueous phase was not measured by gas chromatography, it was estimated using the data reported by Akata and Boyle for 25°C and 35°C. 14 Concentrations of isoflurane are expressed as volumes percent (vol%) in 100% oxygen and as the estimated molar concentration in solution (mmol litre -1 ).
Solution exchanges were accomplished by flushing the recording chamber (1.5 ml in volume) at a flow rate of 4~5 ml min -1 , and to minimize the loss of isoflurane from the solution, freshly bubbled solution was applied every 1 min. As the amplitude of I Ba was not affected by the steps involving solution exchange in the present experiments, we concluded that loss of isoflurane from the solution was minimal during the time required for current recording. Calsiceptine (Cal), ω-conotoxin GIVA (ωCgTX), ω-agatoxin IVA (ωAgTX) (all from Peptide Institute, Minoh, Japan) and nicardipine (Sigma Chem.) were dissolved in deionized water and diluted to their final concentrations in 403 the bathing solution. The concentrations of Cal, ωCgTX, ωAgTX and nicardipine were ജ2 µmol litre -1 , ജ3 µmol litre -1 , ജ2 µmol litre -1 and 5 µmol litre -1 , respectively. These concentrations have been reported to selectively block the L-(nicardipine and Cal), N-(ωCgTX) and P/Q-(ωAgTX) type I Ba . 12 13 
Whole-cell patch clamp recording
The I Ba of DRG cells were recorded in a whole-cell configuration using a patch-clamp amplifier (Axopatch 200A; Axon Instruments, Foster City, CA, USA). Voltage stimulation and current acquisition were carried out through an AD/DA converter (ITC-16, Instrutech, Great Neck, NY, USA) using software (Axodata; Axon Instruments) installed in a PC (PowerMac 7100/80AV; Apple; Cupertino, CA, USA). Current signals were filtered at 2 kHz using a builtin low-pass filter, and data were stored in the PC at a sampling rate of 5 kHz. Patch-pipettes were prepared from borosilicate glass capillary tubes (34502; Kimble Products, Owens, IL, USA) using a multiple-step patch-electrode puller (P-97; Sutter Instrum., Novato, CA, USA) and a heat-polisher (MF-83; Narishige Sci. Instrum. Lab., Tokyo, Japan). In our experiments, electrode resistances of 1.5-3.0 MΩ were used. The patch-electrode was manipulated with the aid of an electrically driven micromanipulator (Manipulator-E, Leitz, Wetzlar, Germany). After obtaining a high resistance seal (1-10 GΩ) by application of a small negative pressure to the pipette, the patch membrane was disrupted by application of a larger negative pressure via the pipette. The successful achievement of the whole-cell voltage-clamp configuration was confirmed by monitoring a sudden change in the capacitative transient. The capacitative transient was then cancelled by adjusting the capacitance compensation and series resistance compensation. Leak current was subtracted from the calcium currents (elicited by step depolarization) using standard P/ n analysis. Current recording was started 5 min or more after rupture of the patch membrane.
Data analysis
Anaesthetic-induced alterations in peak amplitude of I Ba are expressed in a relative manner. In 40 of 350 cells (11.4%), peak amplitude of I Ba was not restored to control values after wash out of isoflurane, especially at high concentrations. As we could not eliminate the possibility of a contribution by the rundown phenomenon to the current change in these cells, data were excluded from analysis if peak current amplitude after removal of isoflurane was less than 90% of control values. Mean amplitude of I Ba at the end of the experiment in the other 310 cells was more than 90% of control values, and data from these cells were subjected to further analysis. The actions of isoflurane were assessed by calculating peak amplitude of the Ba current 4-5 min after application of the anaesthetic. Data are expressed as mean (SD). Statistical significance was assessed using a Student's t test or multivariate analysis of variance (SPSS software; SPSS Inc., Chicago, IL, USA) with significance set at Pϭ0.05.
Decay of I Ba was fitted to the following equation:
where I t , I max , A, t, τ f and τ s are the amplitude of I Ba at time 't', peak amplitude of I Ba , relative amplitude of the first component, time after the peak amplitude I Ba and time constants for the fast and slow components of current decay, respectively. Steady-state activation and inactivation curves were fitted to a Boltzmann equation:
where I and I max are the relative amplitudes of the I Ba evoked by a test pulse either after application of various amplitudes of conditioning pulse (I) or in the absence of a conditioning pulse (I max ); V is the amplitude of the conditioning pulse; V h is the amplitude of the conditioning pulse needed to reduce the amplitude of I Ba to 50% (for the inactivation curves) or the amplitude of the test pulse needed to produce 50% of the maximum current (for the activation curves); k is the slope factor; and C is the fraction of I Ba accounted for by the non-inactivating component. The dissociation constant for drug binding to inactivated calcium channels can be estimated using the following equation 15 :
where ∆V hi is the absolute value of the shift in the voltagedependent inactivation curve resulting from the presence of isoflurane; k is the value of the slope factor for the inactivation curve; [N] is the concentration of isoflurane; and K i and K r are the dissociation constants for the inactivated and resting states of the calcium current, respectively.
Results
Effects of isoflurane on L-type calcium currents in rat DRG cells
Calcium channels in rat DRG cells were pharmacologically classified into four types. An appropriate mixture of the selective blockers for the various types of I Ba (Cal 2 µmol litre -1 , nicardipine 5 µmol litre -1 for the L-type, ωCgTX 3 µmol litre -1 for the N-type and ωAgTX 2 µmol litre -1 for the P/Q-type) was used as pretreatment before application of isoflurane to isolate one of the I Ba (together with the toxinresistant I Ba ). As the ratio between the various types of I Ba differed in individual cells, the amplitude of I Ba used in this study was determined by application of the appropriate specific blocker after recording the effects of isoflurane. To study the toxin-resistant I Ba , a mixture of Cal 2 µmol litre -1 , ωCgTX 3 µmol litre -1 and ωAgTX 2 µmol litre -1 was used as pretreatment. To determine the amplitude of the toxin-404 resistant Ba current, Cd 100 µmol litre -1 was applied at the end of the experiment. Figure 1 shows a diary plot of the peak amplitude of the L-type I Ba in the presence and absence of 1.0% isoflurane (Fig. 1B) and representative whole-cell current traces (Fig. 1A) . Isoflurane produced a reversible decline in peak amplitude of the L-type I Ba . Maximum inhibition was obtained within 5 min of application of isoflurane. Mean reduction in amplitude of the L-type I Ba , induced by 10% isoflurane, was 59.8 (SD 1.1)% (nϭ5). Figure 1C shows the current-voltage relationships obtained in the presence and absence of 1.0% isoflurane. Maximum amplitude was obtained at ϩ10 mV for the L-type I Ba . As peak amplitude of the I Ba differed between cells, the current recorded using a depolarizing pulse to ϩ10 mV was normalized to 1.0, and peak amplitudes of The Ba current was evoked by a depolarizing pulse to 0 mV from a holding potential of -60 mV (30 ms duration at a frequency of 0.18 Hz). At the end of the experiments, ωCgTX 3 µmol litre -1 and Cd 100 µmol litre -1 were applied, and the maximum amplitude of the N-type Ba current was estimated by subtraction of the current recorded after application of ωCgTX from that recorded before application of ωCgTX. A: Representative traces of N-type Ba current before and after application and after removal of 1.0% isoflurane. Traces (a)-(e) were recorded at the times indicated by the same letters in the sequential plot of peak current amplitude. B: Sequential plot showing changes in the peak amplitude of the N-type Ba current. The N-type Ba current was evoked by a depolarizing pulse to 0 mV from a holding potential of -60 mV (30 ms duration at a frequency of 0.18 Hz). C: Current-voltage relationships for the N-type calcium current in the presence and absence of 1.0% isoflurane (mean (SD)). *PϽ0.05 (isoflurane vs after control (wash)). D: Mean effects of 3.0% isoflurane on the peak amplitude of N-type Ba current in DRG cells. Each symbol indicates mean (SD) (nϭ5-8).
I Ba recorded using depolarizing pulses of various intensities were expressed in a relative manner. Isoflurane 1.0% inhibited the L-type I Ba , and the curves representing the current-voltage relationships in the presence and absence of isoflurane came together at ϩ60 mV or more. The inhibitory actions of isoflurane on the L-type I Ba were observed predominantly at positive rather than at negative membrane potentials.
Dual actions of isoflurane on N-type calcium currents in DRG cells
As shown in Figure 2A and 2B, 1.0% isoflurane transiently augmented and then inhibited the N-type I Ba in DRG cells. Augmentation of the N-type I Ba was recorded in most cells tested (35 of 40 cells), although no such augmentation was seen in experiments on the other types of I Ba . Continuous superfusion with 1.0% isoflurane gradually inhibited the N-type I Ba to 65.7 (4.3)% of control, and removal of isoflurane restored peak amplitude to control levels ( Fig. 2A,  B and D) . The subsequent application of ωCgTX 3 µmol litre -1 completely inhibited the residual I Ba (Fig. 2A, B) . The current-voltage relationships for the N-type I Ba in the 405 presence and absence of 1.0% isoflurane are shown in Figure 2C . Figure 2D illustrates the changes that occurred in mean amplitude of the N-type I Ba during and after application of 3.0% isoflurane (nϭ5). At this concentration, isoflurane produced a phasic augmentation (to 132.0 (6.4)% of control) followed by sustained inhibition (to 37 (11.8)% of control).
Effects of isoflurane on P/Q-type and toxin-resistant Ba currents in rat DRG cells
A concentration of 1.0% isoflurane also reduced the P/Qtype I Ba (to 83.5 (2.0)% of control; nϭ5) (Fig. 3A, B) . Subsequent application of ωAgTX 2 µmol litre -1 further reduced the calcium current (to 5% of control) and Cd 100 µmol litre -1 abolished it completely (Fig. 3B) . The current-voltage relationships for the P/Q-type I Ba in the presence and absence of isoflurane (3.0%) are shown in Figure 3C . In contrast, 3.0% isoflurane did not inhibit the toxin-resistant I Ba (nϭ3; data not shown). In all cases, the toxin-resistant I Ba was inhibited by application of CdCl 2 100 µmol litre -1 .
Fig 3
Effects of isoflurane on P/Q-type Ba current. For estimation of the amplitude of the P/Q-type Ba current, cells were first soaked in a solution containing Cal 3 µmol litre -1 and ωCgTX 3 µmol litre -1 and, at the end of the experiment, ωAgTX 2 µmol litre -1 was applied to determine the maximum amplitude of the P/Q-type Ba current. A: Example of the currents recorded in the presence and absence of 1.0% isoflurane. Traces (a)-(e) were recorded at the times indicated by the same letters in the sequential plot of peak current amplitude. B: Sequential plot showing changes in peak amplitude of the P/Q-type Ba current. The P/Q-type Ba current was evoked by a depolarizing pulse to 0 mV from a holding potential of -60 mV (30 ms duration at a frequency of 0.18 Hz). C: Currentvoltage relationships for the P/Q-type Ba current in the presence and absence of isoflurane (mean (SD)). *PϽ0.05 (isoflurane vs after control (wash)).
Relationships between concentration of isoflurane and its effect on peak amplitude of I Ba
The dose-response relationships for the effects of isoflurane on the L-, N-and P/Q-type I Ba are summarized in Figure 4 . Isoflurane inhibited these I Ba , but not the toxin-resistant I Ba , in a concentration-dependent manner, and the curves were well fitted by a simple Michaelis-Menten-type equation with a Hill coefficient of 1.0. The IC 50 values for isoflurane in respect of the L-, N-and P/Q-type I Ba (recorded at a holding potential of -60 mV) were 0.7%, 1.3% and 3.0%, respectively (nϭ5). These values increased to 1.3%, 2.2% and 4.0%, respectively, when Ba currents were recorded at a holding potential of -80 mV, suggesting the presence of voltage-dependent inhibition.
Transient augmentation of the N-type I Ba was also Estimated molar concentrations in the aqueous phase are also shown (in parentheses). In (A), a P value between dose-response curves of the L-, N-and P/Q-type Ba currents, estimated by multivariate analysis of variance, was less than 0.05. *, † and ¶ indicate a P value less than 0.05 (*, L-type vs N-type, ‡, L-type and P/Q-type; †, N-type vs P/Q-type; ¶, augmentation vs inhibition of N-type current). In (B), * and † indicate a P value less than 0.05 for the difference between holding potentials of -60 and -80 mV for the L-and N-type currents, respectively.
observed in a concentration-dependent manner (0.5-3.0%). However, at 5.0% isoflurane, the amplitude of the N-type I Ba decreased with little or no initial increase. This might L-type Ba current with or without 0.7% isoflurane. B: N-type Ba current with or without 1.3% isoflurane. C: P/Q-type Ba current with or without 3.0% isoflurane. A depolarizing pulse to 0 mV (800 ms duration) from a holding potential of -60 mV was applied in the presence or absence of isoflurane. Peak amplitude of each type of Ba current was normalized to 1.0 in the presence or absence of isoflurane; the amplitude of the decaying current was then expressed in a relative manner. Each symbol indicates mean (SD) (nϭ3-5).
have resulted from the simultaneous appearance of the excitatory and inhibitory effects of isoflurane.
Effects of isoflurane on the time course of the current decay induced by a long depolarizing pulse
When a long depolarizing pulse (800 ms duration) was applied, the L-, N-and P/Q-type I Ba were reduced in amplitude in a time-dependent manner. In each case, decay of the calcium currents was well fitted by the double exponential curve (see Methods, eqn (1)) (Fig. 5) . In the absence of isoflurane, the best fit to the actual current decay was obtained with a τ f value of 125 (25) (Fig. 5) .
Effects of isoflurane on the activation and inactivation curves for each type of I Ba
To investigate the effects of isoflurane on the steady-state inactivation curve for each type of I Ba , a double-pulse procedure was used involving an 800-ms conditioning prepulse followed by a brief test pulse (50 ms duration). In the absence of isoflurane, peak amplitude of the L-type I Ba evoked by the test pulse was reduced by the conditioning pulse in a depolarization-dependent manner. The results were well fitted to a Boltzmann equation (eqn (3)). In the absence of isoflurane, a V h value of -24.9 (4.5) mV (nϭ3) was obtained for the L-type I Ba and isoflurane (0.7%) shifted the voltage-dependent inactivation curve in the negative direction (V h ϭ-48.2 (5.3) mV; nϭ3; PϽ0.05) (Fig. 6A ). Voltage-dependent inactivation and activation curves were also obtained for the N-and P/Q-type I Ba (Fig. 6B, C) . In the absence of isoflurane, voltage-dependent inactivation curves with V h values of -42.4 (4.5) mV (nϭ3) and -33.2 (5.0) mV (nϭ3) were obtained for the N-and P/Q-type I Ba , respectively. Isoflurane 1.3% and 3.0% reduced the peak amplitudes of the N-and P/Q-type calcium currents by 50% and shifted the voltage-dependent inactivation curves to the left, with V h values of -57.0 (3.7) mV (nϭ3; PϽ0.05; N-type) and -44.1 (5.8) mV (nϭ3; PϾ0.05; P/Q-type). However, the same concentrations of isoflurane did not shift the activation curves for the N-and P/Q-type I Ba (N-type: control 35.1 (3.4) mV, 1.3% isoflurane 35.6 (3.8) mV, nϭ3; P/Q-type: control 6.3 (3.3) mV, 3.0% isoflurane 8.9 (3.6) mV, nϭ3). Figure 7 shows the effects of isoflurane on the time course of reactivation for each type of I Ba . In this experiment, a long pre-pulse and short test pulse were applied to DRG cells in the presence or absence of isoflurane. With a short interval between the pre-and test pulses (100 ms), the amplitude of I Ba elicited by the test pulse was reduced by approximately 80% of that recorded without a pre-pulse. In the absence of isoflurane, increasing the pulse interval restored the current amplitude evoked by the test pulse, with a 10-s interval completely restoring the L-, N-and P/ Q-type I Ba . The reactivation curve for each type of I Ba
Effects of isoflurane on the reactivation curve of the peak amplitude among Ca 2ϩ channel currents
Fig 6
Effects of isoflurane on the voltage-dependent activation and inactivation curves for each type of Ba current in DRG cells. For the inactivation curves, the amplitude of the Ba current recorded using a conditioning pulse of -80 mV was normalized to 1.0, and the current amplitudes recorded using conditioning pulses of other amplitudes were expressed in a relative manner. For the activation curves, the peak amplitude of the tail current elicited on cessation of a depolarizing pulse of ϩ80 mV was normalized to 1.0. A: L-type Ba current before (s), during (n) and after removal (d) of 0.7% isoflurane. B: N-type Ba current before (s), during (n) and after removal (d) of 1.3% isoflurane. C: P/Qtype Ba current before (s), during (n) and after removal (d) of 3.0% isoflurane. Data were fitted to a Boltzmann equation. Each symbol indicates mean (SD) (nϭ3). *PϽ0.05. comprised fast and slow components, and results were fitted to a double exponential curve. The three types of I Ba exhibited similar values for the time constants of the fast and slow components (τ f and τ s , respectively): L-type, τ f ϭ 0.20 (0.01) s, τ s ϭ 3.00 (0.51) s (nϭ3); N-type, τ f ϭ0.22 (0.01) s, τ s ϭ 3.31 (0.82) s (nϭ5); P/Q-type, τ f ϭ0.22 (0.03) s, τ s ϭ 3.12 (0.13) s (nϭ3). For the L-and N-types, more than 70% of the inactivated current was restored rapidly, but the corresponding value was only 52% for the P/Qtype. In the presence of 0.7% isoflurane, τ f and t s values for the L-type I Ba were both increased (τ f ϭ0.84 (0.05) (nϭ 3; PϽ0.05); τ s ϭ18.0 (4.5) s (nϭ3; PϽ0.05)) and the fast Relative amplitude of Ba current evoked by a test pulse to 0 mV from a holding potential of -60 mV (30 ms duration) is plotted against the interval between a long pre-pulse (800 ms duration; depolarization to 0 mV) and the test pulse. In each case, the peak amplitude of the Ba current evoked by the test pulse was divided by that evoked by the pre-pulse. Each symbol indicates mean (SD) (n ϭ 3-5). *PϽ0.05. component of recovery was reduced to 58% from 76% (control). Isoflurane (1.3% for the N-type and 3.0% for the P/Q-type) also increased τ f and τ s for the N-and P/Q-type I Ba (N-type, τ f ϭ0.63 (0.11) (nϭ5; PϽ0.05); τ s ϭ11.5 (3.4) s (nϭ5; PϽ0.05); P/Q-type, τ f ϭ0.78 (0.14) s (nϭ3; PϽ0.05); τ s ϭ13.9 (2.0) (nϭ3; PϽ0.05)). Isoflurane also reduced the fast component of recovery to 51% from 71% for the N-type calcium current. In contrast, isoflurane did not change the fast component of recovery (52% vs 55%) for the P/Q-type I Ba .
Discussion
Our main finding was that ഛ5% isoflurane inhibited L-, Nand P/Q-type I Ba by enhancing current inactivation and delaying recovery from inactivation. We also found that isoflurane had a transient enhancing effect on the N-type I Ba , an effect that has not been reported previously for any volatile anaesthetic.
Isoflurane is used normally at inhaled concentrations of 0.5-3% for induction and maintenance of anaesthesia. These concentrations of isoflurane in the gas phase are equivalent to 0.12-0.68 mmol litre -1 in the aqueous phase at 37°C. 14 16 At 25°C (the temperature used in our experiments) the same concentrations of isoflurane in the aqueous phase were achieved with 0.24-1.32% in the gas phase. 14 At 0.2% (0.09 mmol litre -1 ) isoflurane, which is slightly lower than the minimum concentration required for induction of anaesthesia, isoflurane inhibited only the L-type I Ba (by 20%). At concentrations of 0.65-1.13% (0.33-0.55 mmol litre -1 ; 25°C), which are equivalent to 1.5-2.5% at 37°C (concentrations used routinely for maintenance of anaesthesia) isoflurane inhibited the L-, N-and P/Q-type I Ba . At 1.0% (0.5 mmol litre -1 ) isoflurane, the L-type I Ba was inhibited by 60%, the N-type by 35% and the P/Qtype by 15%. This indicates that isoflurane had its greatest effect on the L-type Ca 2ϩ channel. However, as isoflurane significantly inhibited the N-and P/Q-type I Ba in addition to the L-type at clinically relevant concentrations, and as N-and P-type channels in nerve terminals are considered to be more important for synaptic transmission than L-type channels, our results suggest that inhibition of all three types of Ca 2ϩ channels may contribute to the anaesthesiarelated actions of isoflurane, such as loss of sensation that occurs as a result of effects on sensory neurones.
A relative insensitivity of P-type channels has been reported in cerebellar Purkinje cells in which isoflurane 0.35 mmol litre -1 inhibited the P-type current by only 8.1% 10 (at 22°C). In our experiments (at 25-28°C), 1.0% isoflurane (0.48 mmol litre -1 ) inhibited the P/Q-type I Ba by 15%, and we estimate that 0.35 mmol litre -1 (0.7%) isoflurane would have caused 8.2% inhibition of this current. We did not record the P-and Q-types separately and therefore we cannot say if isoflurane inhibits both the P-and Q-type channels in DRG cells. Although the general properties of the toxin-resistant component of I Ba have not yet been clarified in DRG cells, our results showed that isoflurane did not affect this current. In the case of the cardiac sodium current recorded at 22°C, a high concentration of isoflurane (2.6%; 0.56 mmol litre -1 , which would reduce the P/Q-type of I Ba in DRG cells by nearly 50%) reduced peak amplitude by only 11%, 17 whereas in rat brain sodium channels transfected into Chinese hamster ovary cells, 0.7% (0.35 mmol litre -1 ) isoflurane inhibited peak current amplitude to 50% at room temperature (24°C). 18 In the case of the potassium currents in canine coronary and cerebral arteries (at 22°C), isoflurane was reported to have weak inhibitory actions. 7 19 Collectively, these results suggest that isoflurane interacts with specific ion channels and that the main targets for isoflurane are possibly L-and N-type Ca 2ϩ channels and TTX-sensitive neuronal Na ϩ channels.
In DRG cells, isoflurane accelerated the decay of the Ntype current (1.3%; 0.68 mmol litre -1 at 25°C) and that of 409 the L-type current (0.7%; 0.35 mmol litre -1 at 25°C), but even at 3.0% (1.46 mmol litre -1 at 25°C) it did not accelerate the decay of the P/Q-type current. These results suggest that voltage-dependent inhibition by isoflurane affected the L-and N-types, but not the P/Q-type Ca 2ϩ channels. A significant acceleration of the decay in the L-type current by isoflurane has also been reported in canine cardiac cells (2.0%) and guineapig portal vein (ജ0.77%; ജ0.18 mmol litre -1 at 35°C). 20 21 In rat hippocampal pyramidal cells, it was reported that isoflurane (2.5%; 1.23 mmol litre -1 at 22°C) produced a slight acceleration in the decay of the Ca 2ϩ current. 9 However, as the L-, N-and P/Q-type currents were not isolated, it is uncertain which type(s) of Ca 2ϩ current were affected. 9 Thus this is the first report showing that isoflurane accelerates decay of the N-type current but not the P/Q-type current. As current decay reflects mainly the transition rate from the open state to the inactivated state, our results suggest that isoflurane does not affect the open state of P/Q-type channels in DRG cells, but that it blocks the open state of the L-and N-type channels.
In our experiments, isoflurane shifted the steady-state inactivation curves for the L-and N-type currents significantly to the left, but not that for the P/Q-type current. A similar leftward shift has been reported for cardiac and neuronal Na ϩ currents and the L-type Ca 2ϩ current in the portal vein. 17 18 21 Furthermore, as halothane and other volatile anaesthetics produce the same effect on Na ϩ -and L-type Ca 2ϩ currents, a leftward shift of the steady state inactivation curve probably represents a common action of volatile anaesthetics on these channels. 17 18 22 If we assume that the sensitivity of L-type currents to isoflurane at resting and inactivated states is as estimated from equation (3), isoflurane blocks the inactivated state of the L-type channel 10 times more strongly than it does the resting state. Similarly, isoflurane blocks the inactivated state of the N-type channels five times more strongly than it does the resting state.
In our experiments, isoflurane (0.7%; 0.35 mmol litre -1 at 25°C) did not shift the voltage-dependent activation curve for the L-type current (Fig. 6) . In contrast, the voltagedependent activation curve for the L-type current has been reported to be shifted to the left by a high concentration of isoflurane (3.3%; 0.74 mmol litre -1 at 35°C) in the guineapig portal vein. 21 This difference might be caused by the different isoflurane concentrations used in the two studies, as a high concentration (1.0 mmol litre -1 at 22°C) of isoflurane, but not a low concentration (0.5 mmol litre -1 at 22°C) was found to shift the voltage-dependent activation curve for the cardiac Na ϩ current significantly in the guineapig. 17 However, in these preparations (guineapig portal vein and cardiac cells), the authors 17 21 also showed that isoflurane shifted the inactivation curve more strongly than the activation curve. From these results, we can speculate that isoflurane, which inhibits mainly L-and Ntype channels, does so by binding to the inactivated state more than to the resting state.
Isoflurane-induced reduction in the number of available L-and N-type calcium channels was also expected from our experiments on current recovery. In DRG cells, recovery from inactivation exhibited two components with fast and slow time constants, respectively, suggesting the presence of two inactivated states for each channel. In the absence of drug, 71% and 76% of the inactivated L-and N-type currents, respectively, were restored rapidly to the resting state (time constants 0.2 s), although these values could be changed by changing the experimental conditions (such as holding potential, amplitude and duration of the pre-pulse). In the presence of 0.7% (0.48 mmol litre -1 at 25°C) or 1.3% (0.68 mmol litre -1 at 25°C) isoflurane, the time constants of the fast and slow components of the recovery increased 3-6 times, and the fast recovery component was reduced to 58% and 51% for L-and N-type currents, respectively. These results indicate that isoflurane inhibited recovery of the L-and N-type channels from the inactivated state to the resting state.
In our experiments, we also found that isoflurane produced transient enhancement of the N-type I Ba in DRG cells, although the mechanism was not elucidated. As far as we know, such an augmentation of a calcium current has not been reported in other cells or with other volatile anaesthetics. In general, anaesthetics have been reported to depress excitatory synaptic transmission, 23 however, there are few reports of excitatory effects of volatile anaesthetics; some studies have demonstrated that halothane and sevoflurane both increase norepinephrine release in the brain and norepinephrine concentrations in the blood in vivo. 24 25 In contrast, halothane decreases norepinephrine release from nerve endings under in vitro conditions. [26] [27] [28] No study has yet been published on the actions of isoflurane on norepinephrine release from nerve terminals. As the enhancing action of isoflurane on the N-type current in DRG cells was over within a few minutes of its administration, and as isoflurane ultimately inhibited all types of calcium currents except the toxin-resistant current, augmentation of the N-type current may make only a minor contribution, if it makes any contribution at all, to the overall effects of isoflurane on the excitability of DRG cells.
